Ma, Nina S.
Mumm, S.
Takahashi, S.
Levine, M. A.
Article History
Accepted: 18 October 2022
First Online: 7 December 2022
Declarations
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: Nina Ma reports grants from Amgen and Ultragenyx, grants and personal fees from Ascendis Pharma, and others from Sophie’s Neighborhood and personal fees from UpToDate.Steve Mumm reports grants from Shriners Children’s and others from Genomenon, Inc.Satoru Takahashi reports grants from Sophie's Neighborhood.Michael Levine reports he has been an investigator on a single-case study of the efficacy of denosumab for MCTO that was funded by Amgen, Inc.
: This article does not contain any studies with human or animal subjects performed by any of the authors.